Analysis of tumor nuclear features using artificial intelligence to predict response to neoadjuvant chemotherapy in high-risk breast cancer patients.
David W DodingtonAndrew LagreeSami TabbarahMajid MohebpourAli Sadeghi-NainiWilliam T TranFang-I LuPublished in: Breast cancer research and treatment (2021)
Analysis of tumor nuclear features using digital pathology/AI can significantly improve models to predict pathological response to NAC.